MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creatore), Mancano, G. (Creatore), Lanni, S. (Creatore), Palumbo, F. (Creatore), Goracci, M. (Creatore), Ferrè, F. (Contributore), Helmer-Citterich, M. (Creatore), Neri, G. (Creatore) (2016). MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells. figshare. 10.6084/m9.figshare.c.3641399_d1.v1